Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004.
about
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery deviceAssessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES.Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) stagingModeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.Development and validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for primary care patients with type 2 diabetesCAM: naturopathic dietary interventions for patients with type 2 diabetes.Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999-2006.Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional SurveySingle, community-based blood glucose readings may be a viable alternative for community surveillance of HbA1c and poor glycaemic control in people with known diabetes in resource-poor settings.Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.Simulation-based Evaluation of the Generalizability Index for Study Traits.Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005-2012.Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension.Multivariate analysis of the population representativeness of related clinical studiesPredicting Noninsulin Antidiabetic Drug Adherence Using a Theoretical Framework Based on the Theory of Planned Behavior in Adults With Type 2 Diabetes: A Prospective Study.Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.Combine and conquer: advantages and disadvantages of fixed-dose combination therapy.Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review.Sulfonylureas and risk of falls and fractures: a systematic review.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.The role of insulin pump therapy for type 2 diabetes mellitus.Changes in Body Weight Among People With Type 2 Diabetes Mellitus in the United States, NHANES 2005-2012.Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study.Medicine-taking experiences and associated factors: comparison between Arabic-speaking and Caucasian English-speaking patients with Type 2 diabetes.Correlates of psychological outcomes in people with diabetes: results from the second Diabetes Attitudes, Wishes and Needs (DAWN2(™) ) study.Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore.Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor.A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.Efficacy and safety of the dietary supplement DBCare® in patients with type 2 diabetes mellitus and inadequate glycemic control.Diabetes: insulin pump therapy for type 2 diabetes mellitus.The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial.Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
P2860
Q30671559-0F47DB8A-0FDB-4A14-830D-9EED3B7D46EBQ30986403-1E7122D1-612D-4591-ABBB-0E812B38E6B4Q31170436-FC0C4D36-0B8F-4682-8762-7AED1B2C1B30Q34144355-19459DBD-80B3-4823-ADA7-837337F2A6D7Q35043641-D01C702B-BB84-40DC-B4C2-1B321B72E46EQ35106978-75CC765D-1F7E-4326-84C9-02AF9F5020D3Q35688240-F89A27AF-50CD-4CE2-BE80-DF2F44B1BE4EQ35772606-DBB2705B-933B-4AE2-8E39-796FD6BC66ADQ36100878-E126D9D4-423F-4C48-93A9-57B39664FED1Q36249641-E58AAAF6-F7E7-423A-8332-0F50AD54A395Q36613155-29C37617-59F7-4B72-BABF-DC128069E0A6Q36765289-B1FDEA73-AFF4-4BF9-BE59-6DAB9ED68D30Q36798684-CE712EF1-8FBB-42D5-B1F2-24F92C7BE6BEQ36813867-770ACE41-D804-4BF0-94FE-7658E4EA1B1BQ36822237-A38D578D-15C8-4E32-B78D-93B058B59D7DQ36872178-A6308DB6-E73E-4D30-84D0-85A92578EAA9Q38046641-6D00F811-E57D-452D-894F-8892F8FC98F3Q38074481-B7C545A0-B0BC-42E1-9C0D-B136EDEF6143Q38101007-6C49C68B-2F5D-47AC-9DD4-C3EF6CF0D8C3Q38641190-350ABD23-0C91-4360-8474-99DC0D143136Q38836724-1834CA62-E368-46C9-926D-E6524A85C1D8Q39873298-EC925290-8823-44B2-876B-1A6FACF7B4B0Q40249013-C521F065-2F9B-44F8-80C7-680AA233B4A5Q40262957-2864C13B-E739-49B2-8EE4-BECD053313A3Q40677771-6B48EBC7-E457-444C-9C31-2806979E3812Q42708363-48CC661B-EAE3-416C-8A93-F9EA1AB42A60Q45807463-5C781DC0-5994-42D1-80F4-2DAADD3685DFQ46986653-1F64DA9B-EB18-448F-A98D-9581CCB654A1Q47916425-61E84487-348C-465D-AF40-87672AECD3BEQ50924825-B79A7003-3FF9-4C2B-8526-4AFF39D25716Q51160241-8E1B6760-3F4D-4176-A752-74E1AC5E3F11Q53476180-33458FCC-28EE-4B0F-91A7-B2A122D3C4CBQ55189416-38508AE3-55EC-4FDA-93C3-90ABD4243DFBQ58053312-F9983F27-7337-4CFE-8DDD-9D6E78F97E17
P2860
Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@en
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@nl
type
label
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@en
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@nl
prefLabel
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@en
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@nl
P2093
P1476
Treatment approach and HbA1c c ...... 2 diabetes: NHANES 1999-2004.
@en
P2093
Allison Hedley Dodd
Cheryl Fahlman
Kristina S Boye
Margaret S Colby
Ronette R Briefel
P304
P356
10.1185/03007990902973300
P407
P577
2009-07-01T00:00:00Z